 |
|
| • |
|
| • |
|
| • |
|
| • |
|
|
| • |
|
| • |
|
| • |
|
| • |
|
| • |
|
|
| • |
|
| • |
|
| • |
|
| • |
|
| • |
|
| • |
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
Div. of Media Relations
1600 Clifton Road
MS D-14
Atlanta, GA 30333
(404) 639-3286
Fax (404) 639-7394 |
|
|
|
 |
October 23, 2001
Contact: CDC Media Relations
404 639-3286
Media Advisory
CDC Addresses Public Health Questions About Anthrax
| WHO: |
Dr. Julie Gerberding, Centers for Disease Control and Prevention (CDC) |
| WHAT: |
Interactive media teleconference: Dr. Gerberding discusses current
information about anthrax. Brief remarks followed by media Q/A. |
| WHEN: |
Thursday, October 25, 2001, 12 Noon – 1 PM ET |
| WHERE: |
At your desk, by toll-free conference line: Dial (800) 288-8968;
Teleconference name CDC/anthrax |
| WHY: |
Provide an overview of the information published in the October 26, 2001,
issue of Morbidity and Mortality Weekly Report (MMWR). Opportunity to address the
following topics:
- Confirmed cases of anthrax
- Monitoring and tracking anthrax
- Testing procedures
- CDC role in investigations
|
|
